German Diabetes Congress (Berlin)DIABETES KONGRESS

The German Diabetes Congress (DIABETES KONGRESS) builds on the success of the inaugural World Diabetes Clinical Trials Conference held in Berlin in November 2016, and will continue to address the numerous complex issues related to diabetes clinical trials. It is evident that streamlining these issues is essential to improving the drug development process regarding approval and commercialization, addressing all aspects of drug and device development, and enhancing methodologies for drug development. (Copyright © Juzhan. Unauthorized reproduction is strictly prohibited.)

The German Diabetes Congress (DIABETES KONGRESS) represents the interests of a growing number of diabetes patients and high-risk populations. Through the study of clinical guidelines, expert consensus, and numerous classic cases, it has achieved diagnostic and treatment standards comparable to those of specialists at internationally renowned hospitals, and is equipped to provide clinical decision support to a broader range of international physicians.

The German Diabetes Congress (DIABETES KONGRESS) provides an ideal forum for the global diabetes community, continuing to advocate for the attention, recognition, and resources that diabetes deserves. It brings together a wide range of global representatives, including physicians, scientists, nurses, other healthcare professionals, government officials, policymakers, media, and diabetes associations. The congress will leverage cutting-edge technology to ensure a safe and dynamic experience for all attendees, helping to prioritize diabetes on the global health agenda and improve the quality of life for patients.